Barclays PLC Has $2.33 Million Position in Doximity, Inc. (NASDAQ:DOCS)

Barclays PLC increased its stake in shares of Doximity, Inc. (NASDAQ:DOCS) by 60.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 53,401 shares of the company’s stock after purchasing an additional 20,125 shares during the quarter. Barclays PLC’s holdings in Doximity were worth $2,327,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Farther Finance Advisors LLC grew its stake in shares of Doximity by 324.2% during the third quarter. Farther Finance Advisors LLC now owns 789 shares of the company’s stock worth $34,000 after buying an additional 603 shares during the last quarter. Quarry LP boosted its holdings in shares of Doximity by 101.2% during the 2nd quarter. Quarry LP now owns 1,616 shares of the company’s stock valued at $45,000 after acquiring an additional 131,253 shares in the last quarter. Morse Asset Management Inc bought a new stake in Doximity during the 3rd quarter worth $46,000. GAMMA Investing LLC grew its position in Doximity by 40.1% during the 3rd quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after acquiring an additional 412 shares during the last quarter. Finally, Van ECK Associates Corp increased its holdings in Doximity by 19.7% in the 2nd quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after purchasing an additional 427 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Analysts Set New Price Targets

Several research firms have recently weighed in on DOCS. Stephens began coverage on Doximity in a report on Friday, December 20th. They set an “equal weight” rating and a $55.00 price target on the stock. Canaccord Genuity Group lowered shares of Doximity from a “buy” rating to a “hold” rating and boosted their target price for the stock from $40.00 to $60.00 in a report on Wednesday, November 13th. The Goldman Sachs Group started coverage on shares of Doximity in a research note on Friday, November 15th. They set a “neutral” rating and a $58.00 price target for the company. Canaccord Genuity Group reissued a “hold” rating and issued a $60.00 price objective (up previously from $40.00) on shares of Doximity in a research note on Wednesday, November 13th. Finally, Mizuho initiated coverage on Doximity in a research report on Wednesday, December 4th. They set a “neutral” rating and a $55.00 target price for the company. Thirteen equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $52.59.

Doximity Trading Up 0.2 %

DOCS opened at $58.27 on Thursday. The company has a fifty day moving average price of $50.00 and a two-hundred day moving average price of $39.47. Doximity, Inc. has a 1-year low of $22.96 and a 1-year high of $61.75. The company has a market cap of $10.88 billion, a P/E ratio of 66.98, a price-to-earnings-growth ratio of 4.16 and a beta of 1.40.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.